The Latest Breaking News from FDA

Nancy Brier suffered all her life from treatment-resistant depression. Then she heard of ketamine therapy. As a 55-year-old mother who’d never even inhaled helium, she was reticent — but decided she had everything to gain and little to lose

Moves by the Biden administration to expand access to a drug first approved in 2000 have spawned multiple lawsuits.

An independent investigation into logging in the Liberian rainforest found illegal operations “on a significant scale,” with multiple missteps or breaches of law by the government agency charged with protecting those forests

COVID vaccinations are likely to become an annual shot in the US. The US Food and Drug Administration on Monday have proposed to make COVID jabs like an annual flu shot. This, reports say, is a simplified approach for future vaccination efforts and will help in a better vaccination coverage…

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

The virus has not yet fully settled into a pattern of seasonality and may never, experts caution.

Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical company was warned over lapses in contamination control and manufacturing practices.

U.S. health officials want to make COVID-19 vaccinations more like the annual flu shot

With rising global medical requirements and continuous technological advancements, the healthcare industry is poised to remain buoyed in the near term. Therefore, quality medical stocks Abbott Laboratories (ABT) and Varex Imaging (VREX) might be solid buys before January ends. However, avoiding fundamentally weak stock SmileDirectClub (SDC) could be wise. Read…